A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.
Year: 2003
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: University of Southern California
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2148511567
